Mark to Market artwork

85: Apollo Hospitals’ recovery from covid is encouraging, but its stock is pricey

Mark to Market

English - September 17, 2020 06:27 - 5 minutes - 5.06 MB
Business News News market price finance podcast investing stock market entrepreneurship business business podcast money market share market entrepreneur Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 84: Investor hopes from Indian IT rise after HCL Tech’s earnings update
Next Episode: 86: Despite near decade-low yields, RBI may need to binge on bonds

Apollo Hospitals Enterprises Ltd’s Q1FY21 revenue contraction is no surprise amid the pandemic. While the firm has done well on the cost front, the stock's pricey valuations seem to factor the brighter picture adequately. You can find more details by tuning in here